Katerina Antoniou is Professor of Pulmonology at the Department of Medicine, University of Crete, and works as a Pulmonologist at the University General Hospital of Heraklion (PAGNI). She is Head of the Laboratory of Molecular and Cellular Pulmonology at the Medical School, University of Crete.
She graduated with honors in 1998 from Naples University, FEDERICO II, then completed her PhD at Medical School, University of Crete, and specialized in Pulmonology in 2005 at the University General Hospital of Heraklion.
She also completed postdoctoral studies with a scholarship from the European Pulmonological Society and as an Honorary Research Fellow at the Royal Brompton Hospital, Imperial College London, with clinical and laboratory research.
She has many years of experience in the management of patients with Pulmonary Fibrosis, Autoimmune Diseases, Sarcoidosis, Severe Asthma and Bronchiectasis, with a particular focus on Interstitial Lung Diseases and the promotion and adoption of precision medicine in clinical practice. In the field of clinical research, she has participated as principal investigator or co-investigator in the conduct of many international and national multicenter clinical studies.
Her work is focused on the Human-Centered care of patients with Interstitial Lung Diseases. To this end, she collaborates with patient associations at international and national levels and participates in the collaboration of the European Respiratory Society (ERS) with the WHO on chronic respiratory diseases. She has participated in the organization of many European and international conferences, such as the World Congress on Interstitial Lung Diseases, WASOG 2018 in Heraklion, Crete. She is also a member of the writing team for international guidelines and the lead author of the recently published ERS EULAR guidelines for autoimmune diseases with interstitial lung involvement.
She has received important awards such as the ERS Research Award in 2012 for her research in Pulmonary Fibrosis and the University of Crete Research Award for 2022.
She is on Stanford's list of 2% top scientists for the influence of her work in her scientific field from 2022 to date. Ms. Antoniou has over 250 publications in international journals that have received ~15000 citations with h-index 59. She is ranked 30th in the World Expertise in Interstitial Lung Diseases list.
She has served as elected member of Deanship of Medical School, University of Crete (2015-2017), President of Public Relations Committee of University of Crete (2016-2018), member of the Board of Directors of European Society (2018-2024), Head of European Pulmonary Society Working Group on Interstitial Diseases (2021-2024) and is member of WASOG board of directors for interstitial lung diseases.

Antonio Anzueto is Professor of Medicine at the University of Texas Health Science Center and Chief of the Pulmonary Section for the South Texas Veterans Health Care System, San Antonio, Texas, USA. In addition, he is a faculty member of the Pulmonary Disease and Critical Care Medicine Division, the Medical Director for the Pulmonary Function Laboratory at the University Hospital in San Antonio, and an adjunct scientist at the Southwest Foundation for Biomedical Research, San Antonio, Texas.
His areas of interest include chronic obstructive pulmonary disease, chronic bronchitis, community-acquired pneumonia, sepsis, acute respiratory distress syndrome, and lung transplantation.
He is a member of a number of medical committees, a reviewer for various scientific journals including the New England Journal of Medicine, and has published over 250 manuscripts in highly rated medical journals. He has extensive research experience as has been the principal investigator of numerous large multicenter clinical trials. He is member of several international committees such as the Global Initiative for Chronic Obstructive Lung Disease (GOLD); ATS/IDSA Community Acquired Pneumonia Guidelines Committee; International committee – consensus conference on ALI/ARDS. He is also a practicing physician that has been nominated over the last 8 years as a “Best Pulmonary Doctor” in San Antonio, Texas.

Dr. Carlos Paeza Marinez is a specialist in pulmonology currently practicing at the General University Hospital of Elche, Alicante, Spain. He is an active member of SEPAR (Spanish Society of Pulmonology and Thoracic Surgery), within the section dedicated to occupational and environmental respiratory diseases. He holds a PhD from Miguel Hernández University, and his primary line of research focuses on the impact of environmental microplastics on the respiratory system.

MBChB, PhD, FRCP
I am an Associate Professor of Respiratory Medicine and Consultant Respiratory Physician. My main focus of work is in translational science in the field of chronic obstructive pulmonary disease (COPD), particularly in exacerbations of COPD. The group investigates the mechanisms and therapeutic strategies aligned to endotypes of COPD.
So far, by studying eosinophils in COPD, this work has shown that evaluation of eosinophils relates to frequency of exacerbations, response to treatment with inhaled steroids, and led to drug discovery using monoclonal antibodies to prevent exacerbations of COPD. My work has influenced international guidelines, such that eosinophils are now measured routinely in clinical practice for treatment initiation and continuation. 

My group is currently investigating the following: 

1. Characterisation of patients with COPD, utilising near-patient point of care testing to deliver systemic corticosteroid treatment at the time of an exacerbation.
2. Using mathematical approaches to investigate biological, physiological and symptom changes in COPD
3. The epithelial cell response to infection, particularly non-typeable H.influenzae and immunity in COPD
4. Establishing the role of the eosinophil in the mechanism of COPD.
5. Developing monitoring devices and tools, with abilities to influence clinical change in asthma and COPD

Prof. Fulvio Braido is Associate Professor in Respiratory Medicine at the University of Genoa, Italy, where he is the Head of the Respiratory Diseases & Allergy Department.
Fulvio Braido graduated cum laude in 1993 at the School of Medicine, University of Genoa and participated to the Respiratory Program Respiratory Diseases in 1993-1997 and in Allergy and Clinical Immunology 2002-2006 at the University of Genoa.
He is a researcher in Rhinitis, Asthma, COPD and Sleep Apnea (HI 38).
His main research interests are represented by development and assessmento f patient reported outcomes in respiratory and allergic diseases andthe physiopathological/immunological mechanisms.
Fulvio Braido has an excellent experience in clinical trials based on Good Clinical Practice. He is heavily engaged in teaching activities for the School of Medicine in Genoa, where he teaches Respiratory Diseases.
He is the president of Interasma - Global Asthma Association, former Executive Committee Member of the European Academy of Allergy and Clinical Immunology (EAACI).
He is the editor in chief of Journal of asthma.

Allergist and Pulmonologist
Giorgio Walter is Professor of Respiratory Medicine at Humanitas University & Director Personalized Medicine Asthma & Allergy Center at Humanitas Research Hospital-Milano Italy Professor Canonica first specialised in pulmonary diseases after receiving his medical degree from the University of Genoa, Italy. He then specialised in allergy and clinical immunology at Florence University, Italy. He subsequently conducted clinical immunology and allergology research at several European Universities and Institutes, in addition to two years at the Medical University of South Carolina, USA. Since returning to the University of Genoa in 1995, Professor Canonica has held a number of academic positions, including Director of the Speciality School of Allergy and Clinical Immunology, Director of the Specialty School of Pulmonary Diseases and Chairman of the Department of Medical Specialties (University Hospital San Martino Genoa, Italy). He is a Board Member of ARIA-Allergic Rhinitis and its Impact on Asthma and helped to develop their guidelines.
He has been President of WAO-World Allergy Organization, Interasma-Global Asthma Association, currently VicePresident of REG-Respiratory Effectiveness Group.
He is Steering Committee Member of SANI-Severe Asthma Network Italy.

Field of Study: Ecology of Terrestrial Systems and Climate Change
Academic Profile: Dr. [Name] specializes in the field of terrestrial ecology and climate change, with a broad scientific background that spans education, teacher training, and personal development. His expertise extends across the life sciences, including biology, biochemistry, and environmental science, with a strong foundation in statistics and applied research. He has also engaged in the fields of agriculture, forestry, and fisheries, with particular emphasis on forestry and the protection of the natural environment and wildlife.
In addition, his academic and professional activities encompass health and welfare, with a focus on the intersection between environmental protection and public health. His multidisciplinary approach reflects a commitment to advancing knowledge in environmental sustainability, climate change, and the training of educators with scientific specialization.

Investigator, RI-MUHC, Glen site
Associate Professor, Department of Medicine, Faculty of Medicine and Health Sciences, McGill University
Department of Medicine, Division of Respiratory Medicine, MUHC
My research interests lie in the phenotyping of asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung disease (ILD) subjects drawn from community practice. My team applies conventional and advanced physiology and imaging techniques and genetic screening for alpha-1 antitrypsin deficiency to improve both sensitivity and specificity of disease detection. Specifically, I work with other centres to standardize whole-breath oscillometry and develop novel intra-breath oscillometry parameters, novel CT scanning biomarkers and new lung function home monitoring technologies.

Wytske J. Fokkens is Professor at the Department of Otorhinolaryngology at the Academic Medical Center in Amsterdam. Her main field of interest is diseases of the nose and sinuses and the relation with the lower airways. She is the chairperson of the European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS). Dr. Fokkens is the author of more than 500 papers on allergy and rhinology. She has written a textbook on Rhinology: Rhinology and Skull Base Surgery, From the Lab to the Operating Room – An Evidence Based Approach. For the last 15 years she has been organising an advanced sinus surgery course that is attended by sinus surgeons from all over the world to learn more extensive sinus surgery. Moreover, she is a frequently invited international speaker with special interest for new treatment options in rhinitis and rhinosinusitis with and without nasal polyps. She is honorary member of EAACI, the Spanish and Greek Societies of ORL, and the Roumanian Rhinologic Society. Specialties of professor Fokkens include: Difficult to treat rhinitis and rhinosinusitis, nasal polyps, sinus surgery, new treatment options for rhinitis and rhinosinusitis. Sinus & skull base surgery and mucosal pathology of the upper and lower airways.

I am a Professor of Cardiovascular Medicine, Honorary Consultant Cardiologist, and Co-Director of the Leeds Institute for Data Analytics at the University of Leeds.
Qualifying in medicine at the London Hospital Medical College and obtaining a BSc (Hons) in Psychology, I worked as a Junior Doctor at the Royal London Hospital. After becoming a Member of the Royal College of Physicians, I was awarded a Medical Research Council Clinical Training Fellowship and completed a Ph.D in molecular biology at the University of Leeds. I undertook specialty training in cardiology principally at the Leeds General Infirmary, where I was a Walport and later a NIHR Academic Clinical Lecturer, then achieving a NIHR Clinician Scientist Award, and subsequently NIHR Clinical Trials Fellowship. I hold a Masters in Clinical Education and a Masters in Biostatistics and Epidemiology.
Presently, I am Honorary Consultant Cardiologist at Leeds General Infirmary where I practice clinical cardiology with particular interests in general cardiology and chronic heart failure. In 2023 I was commissioned by the UK Public Inquiry into Covid-19 to serve as the Independent Expert for Cardiovascular Disease for the Impact of Covid-19 Pandemic on Healthcare Systems in the 4 Nations of the UK (Module 3). I Co-Chair The Lancet Regional Health – Europe Commission on Inequalities and Disparities in Cardiovascular Health.
I am a trialist and health services researcher. My research incorporates the use of observational and randomised data to deliver population-based studies of cardiovascular care and outcomes. I lead a research active group at the Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds. I hold major research awards predominantly from the NIHR, British Heart Foundation and Horizon 2020. I have published over 375 research manuscripts in peer reviewed journals including JAMA, Lancet, BMJ, EHJ amounting to over 150,000 citations, with H index 100.
I am a Fellow of the Royal College of Physicians of London, Fellow of the European Society of Cardiology and member of the British Cardiovascular Society. I am Clinical Lead for the UK nationwide heart attack register (Myocardial Ischaemia National Audit Project, MINAP), the largest continuous collection register of heart attacks in the world which is used to inform care quality in the NHS. I am Section Editor for the ESC Textbook of Cardiovascular Disease.
I hold leadership positions which harmonise with my clinical and academic interests, including Executive Committee member of EuroHeart and immediate past Chair of the European Society of Cardiology Quality Indicator Committee. I have recently completed a 10-year term as member of the NICE Indicator Advisory Committee. I Chair a number of Data Monitoring Committees for Randomised Clinical Trials.

Prof Gibbons Michael graduated from the University of Glasgow with an intercalated BSc (Hons) (1st Class) in Molecular Biology in 1995, and MB ChB in 1998. He undertook his basic medical training in Glasgow before moving to Edinburgh in 2001 to train in Respiratory Medicine. He was awarded an MRC Clinical Research Training Fellowship in 2007 to study mechanisms in the pathogenesis of pulmonary fibrosis; he was awarded his PhD from the University of Edinburgh in 2010. He trained in interstitial lung disease (ILD) in Edinburgh and has also spent time at the National Jewish ILD Program in Denver, US.
Prof Gibbons moved to Exeter in 2010 where he established and is currently the Clinical Director for the Regional NHSE Specialised Commissioned Exeter - South West Peninsula ILD Service. He is Lead of the Academic Respiratory Department of the Royal Devon University Healthcare NHS Foundation Trust. He is Principal Investigator for multiple clinical trials (Phase 1-IV). Prof Gibbons is the Clinical Director of the Clinical Research Network: South West Peninsula. He is a past Chair of the British Thoracic Society (BTS) Specialist Advisory Group for Interstitial & Rare Lung Disease, a member of the BTS ILD Registry, BTS Science & Research Committee and BTS Council. He is a member of the European Respiratory Society, the American Thoracic Society, and the British Association for Lung Research.
Prof Gibbons is a Senior Investigator Fellow and co-supervises two PhD students – Emily Plumpton (with Dr Peter Cook & Professor Chris Scotton) and Ben Bowhay (with Dr Owen Tomlinson & Professor Chris Scotton). He also co-supervises an Exeter MRC Medical Mycology Centre Clinical PhD Fellow (Dr Matt Steward) and a Wellcome Trust GW4-CAT Clinical PhD Fellow (Dr Giles Dixon). He is the Chief Investigator of the CHORUS study, an NIHR HTA Funded Multi-Centre RCT (£2.3M) and co-investigator on the NIHR HTA funded MucACT COPD trial (£1.6M). He co-leads the Pulmonary Fibrosis Lung Sounds study and the STARSHIP study: A Study of Telomeres And role of Sex Hormones in Pulmonary Fibrosis.

Professor Halpin was appointed as a Consultant Physician and Senior Lecturer in Respiratory Medicine in Exeter in 1994. He has a busy clinical practice and for 13 years he was Clinical Lead for the Department in Exeter, overseeing the growth in its clinical and research activity. He is also Honorary Professor of Respiratory Medicine at the Observational and Pragmatic Research Institute (OPRI) in Singapore. He is a member of the Board of Directors of the Global Initiative on Obstructive Lung Diseases (GOLD) and of the GOLD Science Committee. He was the Chairman and Clinical Expert for the COPD Guideline Development Group of the National Institute of Clinical Excellence (NICE) in the UK.
He studied medicine at Brasenose College, Oxford University (first class honours) & St Thomas Hospital Medical School, qualifying in 1986. He was awarded an MRC scholarship to undertake a D.Phil. in the Department of Human Anatomy at Oxford University, between his pre-clinical and clinical training. He trained in respiratory medicine at the Royal Brompton Hospital in London.
He is a Fellow of Royal College Physicians, and a Member of the British Thoracic Society (BTS), European Respiratory Society (ERS) & American Thoracic Society (ATS). He has served on various BTS committees. In 2018 he was elected as a Fellow of ERS in recognition of lifetime excellence and contributions to research, education and clinical leadership in respiratory medicine.
Interests:
His research is focused on clinical aspects of COPD and asthma.
He has led studies on the pharmacological treatment of asthma and COPD, including the effects of long acting-bronchodilators, inhaled corticosteroids and biologic therapies. He has recently led a real world pragmatic RCT examining the benefits of single versus multiple inhaler therapy in COPD. Recent work has also looked at the role of biomarkers as predictors of therapeutic response.
He has also had a longstanding interests in the role of palliative care for patients with COPD and the role of psychological factors in COPD and asthma.
Qualifications:
BA Physiological Sciences, First Class, University of Oxford, 1981
DPhil, University of Oxford, 1983
MA, University of Oxford, 1983
MB BS, St Thomas's Hospital Medical School, London University 1986
MRCP, Royal College of Physicians London 1989
FRCP, Royal College of Physicians London, 1999
FERS, European Respiratory Society, 2018

MD CCFP(EM) FCFP
Family Physician practicing in York Region, Ontario, Canada.

Chairperson of the Family Physician Airways Group of Canada (www.fpagc.com)
Past- Chairperson of the Respiratory Section of the College of Family Physicians of Canada
Senate member of the International Primary Care Respiratory Group
President of the IPCRG 5th biennual world scientific meeting, “Making Every Breath Count” Toronto June 2-5, 2010
Chair of the Council of Organizing Members of the Canadian Network for Respiratory Care.
Member of Past Canadian Consensus Guidelines for H pylori, Asthma, COPD and Sinusitis
Representative of the College of Family Physicians of Canada to the SARS clinical working group.
Member of Chronic Respiratory Disease Surveillance Advisory Committee (Public Health Agency of Canada)
Member of the Health Canada Section on Allergy and Respiratory Therapies
Member of the Canadian Metropolitan Tuberculosis Subcommittee
Co-Chair, Health Quality Ontario COPD Community Management standards committee
Board member, Thrombosis Canada
Vice President, Respiratory Effectiveness Group

International editor for Nature’s Primary Care Respiratory Journal
International editor for the Italian Journal of Primary Care

Non-respiratory medical interests:
Community Pain consultant
Palliative Care community physician
Hospitalist, Brampton Civic Hospital

Social:
Married with four children and four dogs
Ardent baseball player

Dr Konstantinos Kostikas is Associate Professor of Respiratory Medicine and Head of the Respiratory Medicine Department of the University of Ioannina, Greece, and Professor of Respiratory Medicine at the Observational and Pragmatic Research Institute, Singapore. He was trained at the University of Athens Medical School and the Royal Brompton Hospital, London, and has worked in academia and the pharmaceutical industry in global medical affairs roles.
Dr Kostikas is a member of GOLD COPD Assembly. He has more than 230 publications in PubMed (h-index 38), focusing on COPD, severe asthma, and new technologies. He is the Editor in Chief of Pneumon Journal (www.pneumon.org), associate editor of COPD: Journal of Chronic Obstructive Pulmonary Disease, and member of the editorial board of American Journal of Respiratory and Critical Care Medicine, PLoS One, Diagnostics and Frontiers in Medicine.

Piotr Kuna currently works at the Division of Internal Medicine, Asthma and Allergy Medical University of Łódź. He does research in Pulmonology, Clinical Immunology and Allergology. One of his most important current project is 'MASK rhinitis mhealth study'.

Thérèse Lapperre is an Associate Professor in Respiratory Medicine at the University of Antwerp and head of the department of Respiratory Medicine at the Antwerp University Hospital (UZA). She has an international background, being trained in the Netherlands and having worked as a pulmonologist and researcher in both Singapore and Copenhagen, Denmark. Her main research interest involves the pathogenesis and management of patients with COPD and asthma, including clinical and mechanistic studies.

- MD, FAAAAI, Dist.Intl.FACAAI
- Directora Centro de Excelencia en Asma y Alergia, Hospital Médica Sur, Mexico City
- GINA Advocate for Mexico 2020-ongoing
- Chair 8 National Guidelines: a.o. Integrated asthma managemente (MIA 2021), Immunotherapy 2019, Consensus Atopic Derm 2018, Asthma 2017, Urticaria 2014 and ARIA México 2014
>190 pubmed indexed publications

Marc Miravitlles is a Pulmonologist at the Hospital Universitari Vall d’Hebron in Barcelona, Spain. He obtained his MD at the Universitat de Barcelona, Barcelona, Spain and then specialised in Respiratory Medicine at Hospital Vall d'Hebron. His primary research interests include chronic obstructive pulmonary disease (COPD), alpha-1-antitrypsin deficiency (AAT), lung defence mechanisms and respiratory infections. He serves on various medical committees and is a member of numerous professional societies, including the Spanish Society of Pneumology and Thoracic Surgery (SEPAR), where he served as Secretary from 1999 until 2003 and responsible for International Relationships from 2006 until 2012. Dr Miravitlles was Chair of the Respiratory Infections Group of the European Respiratory Society (ERS) from 2008 to 2011 and was the Guidelines Director of the ERS from 2015 to 2018. He has acted as a consultant for the development of different international guidelines of COPD, including the American Thoracic Society (ATS)/ERS task force on outcomes in COPD, the ERS/ATS guidelines on exacerbations of COPD and the ERS statement on management of alpha-1 antitrypsin deficiency. He is also a consultant of the Spanish Ministry of Health for the development of the National Strategy Against COPD (2009 to present). He is the coordinator of the Spanish National Guidelines for COPD (GesEPOC from 2012).

Prof. Papadopoulos is Professor of Allergy and Paediatric Allergy at the University of Manchester, UK, and the Chair of Allergy and Pediatric Allergy at the University of Athens (NKUA), Greece.
He has extensive clinical and educational experience in paediatric allergy, having headed for many years a unit caring for more than 7,000 children with allergic diseases yearly, implementing state-of-the-art interventions and training medical students, resident paediatricians and allergists.
His research focus is the interface between infection and allergic disease, with an emphasis on asthma exacerbations and food allergy. He is the Coordinator of the EU-funded CURE project. He has extensive collaborations in the context of EU projects, such as PreDicta, GA2LEN, EUROPREVALL, iFAAM and FAST.
Prof. Papadopoulos has published over 300 papers (h-index: 70), has received several international awards and is invited to speak at international scientific meetings some 30 times a year. Moreover, he has served or is serving on the boards of EAACI, GA2LEN, WAO, EFA and ARIA. He was the 2013–2015 President of EAACI and is currently the President of the Respiratory Effectiveness Group (REG).

Hilary is a family physician and Professor of Primary Care Respiratory Medicine at the University of Edinburgh. Her research interests focus on delivery of care including implementing supported self-management for asthma, remote consulting and digital health for respiratory disease, pulmonary rehabilitation in low resource settings, and supportive care for people with severe COPD.

Pippa Powell is Director of the European Lung Foundation (ELF). ELF works to ensure people living with lung disease have access to evidence-based information and the opportunity to influence respiratory research and guidelines at a European level. ELF has >200 patient organizations in its patient organization network from 51 countries. It also has 13 disease-specific patient advisory groups, which provide input and advise on the priorities important to patients.

Klaus F. Rabe, MD, PhD, FERS, is Professor of Pulmonary Medicine at the University of Kiel and Director of the Department of Pneumology, LungClinic Grosshansdorf, Germany.
Prof. Rabe is a Fellow and Past President of the European Respiratory Society and currently serves as Vice Chairman of the German Center for Lung Research. He is the Past President of the German Chest Society, and a member of the British Pharmacological Society and the American Thoracic Society. He has served on committees for the Global Initiative for Asthma (GINA) and the Global Initiative for Chronic Obstructive Lung Disease.
Prof. Rabe serves on the editorial board of several journals including the American Journal of Respiratory and Critical Care Medicine and is past Chief Editor of the European Respiratory Journal. He received several distinctions including the Balzan award in 2019.
Prof. Rabe has been active in various fields of respiratory medicine worldwide. His current scientific interests are related to large clinical trials in COPD and asthma, the mechanisms of airway inflammation, and early determinants of lung health. Prof. Rabe has been involved in many major COPD trials, including the pivotal studies on phosphodiesterase inhibitors and biologics for asthma and COPD.

Nicolas Roche is Professor of Respiratory Medicine at Cochin Hospital, University of Paris Descartes, France. His major areas of interest are COPD and asthma with particular focus on inhaled therapy, disease phenotypes, assessment tools, treatment strategies and real-life research. Professor Roche is a member of the GOLD science committee, President of Société de Pneumologie de Langue Française, co-chair of the 2018 ERS Congress and member of the American Thoracic Society. He is guidelines director of the ERS and member of the ERS Clinical Research Collaboration (CRC) working group and ERS Science Council, vice-president of the Respiratory Effectiveness Group and member of the Asthma Drug Management Improvement Team. He coordinates French guidelines on COPD and is a consultant for French institutions for the development of national projects on COPD.
Professor Roche has authored more than 250 research articles in international peer-reviewed journals and edited or co-edited several books on COPD. He is Associate Editor of the European Respiratory Review and the Clinical Respiratory Journal.

Miguel Roman Rodriguez co-founded the Spanish Society of Family Medicine –semFYC- Respiratory group and was the international representative of GRAP, the primary care respiratory group of Spain. He has led the International Primary Care Respiratory Group and continues to practice in his local community and the emergency room at his local hospital; IBSalut (Balearic Health System). He is also the incoming ERS General Practice and Primary Care Group 1.3 Chair.

Dermot Ryan is a recently retired GP who has had a long-term interest in Respiratory and Allergic diseases regarding primary care. He was previously chair of Primary Care Society during which time he was instrumental in establishing the professorial post of Professor in Primary Care Respiratory Medicine, the first ever clinical discipline to be established in any academic department of primary care. During this time, he was involved in the set-up of what is now npj Primary Care Respiratory Medicine. The purpose of these two activities were to research real life solutions to the real-life problems encountered in daily practice and provide a vehicle for the dissemination of this research. He was previously the Clinical Respiratory lead of East Midland Strategic Health Authority. He was the first chair of the primary care interest group of EAACI where he served (and is still serving) on many task forces. He succeeded David Price as president of REG and in turn was succeeded by Nikos Papadopoulos. He is Honorary Clinical Research Fellow at the University of Edinburgh.

Professor Schleich is professor of human physiology and exercise physiology at university of Liege, Belgium and a Respiratory physician at University Hospital of Liege, Belgium.
She is president of the Belgian Respiratory Society, Co-chair of SHARP and Secretary of ERS Assembly 5.

Associate Professor of Medicine, Universidad Autónoma de Madrid, and Senior Investigator at the Instituto de Investigación Hospital Universitario de la Princesa-IISP, Madrid, Spain
Bariton at the Opera Choir of Teatre Principal de Palma, Palma de Mallorca, Spain

Joan B Soriano graduated in Medicine in 1993 and received his Ph.D. in Epidemiology and Methodology of Biomedical Research in 1996, both from the Universitat Autònoma de Barcelona. He completed his education in Epidemiology with a Master of Science at the Erasmus University Rotterdam, The Netherlands, and a post-doctoral stay at the Johns Hopkins School of Public Health, in Baltimore, USA. He worked in the pharmaceutical industry in the UK from 1998, and later in the USA from 2003. In 2005 moved back to CIMERA in Mallorca, Spain, up to its closing. From 2015, he is Associate Professor of Medicine at the Universidad Autónoma de Madrid, Senior Investigator at the Instituto de Investigación Hospital Universitario de la Princesa-IISP, both in Madrid.

He serves in the GesEPOC COPD guidelines, has been Methodologic and Scientific Consultant of SEPAR and Director of its Foreign Affairs, participates in several committees of the Ministry of Health of Spain, and collaborates extensively with both the ERS and CHEST. He spends most of his time dedicated to research on COPD and other respiratory conditions, aging and tobacco, the design of new clinical trials and translational Medicine. Since 2007 he is Associate Editor of the European Respiratory Journal and since 2012 of the Lancet Respiratory Medicine, and peer reviews extensively for others. He has 300+ publications in PubMed in the fields of clinical epidemiology and treatment of respiratory diseases, and a Hirsh index of 80+. In May 2011 he received the Josep Trueta Award for scientific and medical achievements, and in 2014 he was appointed FCCP from Chest and Foundational Fellow of the ERS (FERS).

He has authored several REG papers and participated actively in many of its past conferences. He is in the REG Board since 2019.

María José Torres holds a degree and a PhD in Medicine and Surgery from the University of Málaga and is a specialist in Allergology. She carries out her clinical and research work at the Regional University Hospital of Málaga, where she serves as Head of the Allergy Department and Research Group Leader. She is also an Associate Professor in the Department of Medicine at the University of Málaga.
She has extensive research experience and is the Coordinator of the Spanish National Network for Asthma and Allergy (RETICs ARADyAL). She leads the Research Group on Nano-structured Systems for the Diagnosis and Treatment of Allergic Diseases at the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) and the Allergy Research Group at IBIMA, where she coordinates the area of infectious and immunological diseases.
Dr. Torres has served as Deputy Director of IBIMA and as Chair of the Málaga Research Ethics Committee. Her main research area is drug allergy, although she also works on food allergy and immunotherapy. She is the Principal Investigator of several nationally and internationally competitive research projects.
She is co-author of over 200 publications in international journals, has presented more than 300 conference papers, and has delivered over 50 lectures. She has received four research awards and holds nine patents, one of which is licensed by Diater Laboratories and currently used worldwide.
Dr. Torres coordinates the Drug Allergy Group of the Spanish Society of Allergy and Clinical Immunology (SEAIC) and has led the Drug Allergy Interest Group of the European Academy of Allergy and Clinical Immunology (EAACI). She is a member of the EAACI Executive Committee, the ISCIII evaluation panel for inflammatory diseases, and the Drug Allergy Committee of the American Academy of Allergy, Asthma & Immunology (AAAAI), among other committees.
She also acts as an evaluator for ANEP projects and serves as panel coordinator for research project evaluations of the Andalusian Regional Government in the area of respiratory and immunological diseases.
Currently, she is Deputy Editor of the journal Allergy, has been Associate Editor for several journals (JIACI, Current Treatment Options, Clinical and Translational Allergy), and serves as a reviewer for leading journals in the field of allergy.

Prof. dr. Job FM van Boven is a health economics & real-world drug outcomes expert specialised in lung diseases. He is the founding director of the Medication Adherence Expertise Center Of the northern Netherlands (MAECON) and Chair of the European Network to Advance Best Practices & Technology on Medication Adherence (ENABLE) COST Action 19132. He is Principal Investigator at the Groningen Research Institute for Asthma and COPD (GRIAC) and leads the research group on Cost-effective Respiratory Drug Use at the University Medical Center Groningen.
He obtained his PharmD and PhD at the University of Groningen (The Netherlands), where his thesis focused on the cost-effectiveness of adherence enhancing interventions in patients with COPD. After his PhD research, he completed fellowships at the University of Colorado (USA), Monash University (Australia) and the Hospital Universitario Son Espases (Spain).
He is (co)author of >100 scientific publications, supervisor of 9 PhD students and received several research prices & grants (totalling>€6 million). Having interest and wide experience in both medication adherence and health economic methods, his mission is to find novel, cost-effective ways to make better use of our respiratory medications in order to maximize both patients’ and societal benefits. Amongst others, his research aims to provide evidence for optimal implementation of drug-device technologies (digital inhalers, electronic pill bottles and smart spacers) in daily clinical practice.

Cláudia Almeida Vicente is a family doctor at USF Araceti in Portugal. She has a special interest in the respiratory area, and since 2013, has been in the coordination group of the Respiratory Diseases Group of the Association of General and Family Medicine. She became the coordinator of the Group in 2021.
Dr. Vicente has been a member of the Board of the International Primary Care Respiratory Group since 2022, and also the President elected. She is Chair of the ERS group 01.03 and is also a member of the Gina Advocacy group.
She has participated in articles, guides and documents useful for clinical practice, promoting respiratory diseases in primary healthcare, as well as the articulation of care with hospital specialties.

Prof. J. Christian Virchow is head of the departments of pneumology and intensive care medicine at the university medical center in Rostock Germany.
He has published more than 260 peer reviewed papers on pulmonary diseases with a focus on asthma and COPD.